Healthcare


Innovative Solutions for Drug Discovery and Development

Share this:
     
Published: 13 Oct 2017

This Drug Discovery TechVision Opportunity Engine (TOE) provides insights across novel methods that improve drug discovery. The service encompasses recent advances in drug discovery technologies that impact precision oncology, targeted cancer therapy, Big Data analytics and Parkinson’s disease management. Lastly, the TOE summarizes key technology trends that leverage stem cell platforms for advancing drug discovery. The Drug Discovery TechVision Opportunity Engine (TOE) reports and analyzes about the latest developments in drug discovery and therapeutics, thereby providing an opportunity to acquire strategic insights into crucial developments in this industry domain. Technologies profiled include those used for biomarker and target discovery such as high throughput screening, signal transduction, micro array, RNAi, metabolomics, toxicogenomics, biosensors and nanotechnology. In addition to these, a fair focus shall be dedicated to the latest trends in therapeutic approaches across a diversity of diseases including infectious, genetic, metabolic, neurological, cardiac, and autoimmune disorders. The Health and Wellness cluster tracks developments in a myriad of areas including genetic engineering, regenerative medicine, drug discovery and development, nanomedicine, nutrition, cosmetic procedures, pain and disease management and therapies, drug delivery, personalized medicine, and smart healthcare. Keywords: Drug discovery, biofluorescence, cancer detection, genome analytics, precision oncology, Big Data analytics, cancer vaccines, cancer biosimilar, Parkinson ’s disease, non-small cell lung cancer (NSCLC), NR0B1, NR0B1, induced pluripotent stem cell (iPSC)

Tools

Features of this research

SUBSCRIPTIONS

Help Desk

Full list of offices


For more information and general enquiries, contact Frost & Sullivan near you.

North America
tel: +1.877.463.7678

Select a location near you..